Analysis of cholesterol levels in lipoprotein(a) with anion-exchange chromatography

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 1237-1243

  Hirowatari, Yuji ^a   Yoshida, Hiroshi ^b   Kurosawa, Hideo ^b   Shimura, Yuko ^a   Yanai, Hidekatsu ^b   Tada, Norio ^b  

^a TOSOH CORPORATION   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerotic risk factor; High performance liquid chromatography; Lipoprotein (a)

Indexed keywords

CHOLESTEROL; CHYLOMICRON; DIETHYLAMINOETHYL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; INTERMEDIATE DENSITY LIPOPROTEIN; LIGAND; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; POLYMER; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOTURBIDITY; MALE; NANOPORE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ULTRACENTRIFUGATION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; CHYLOMICRONS; FEMALE; HUMANS; LINEAR MODELS; LIPOPROTEIN(A); MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS; ULTRACENTRIFUGATION;

EID: 77951070853     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D003624     Document Type: Article

References (27)

1. Berglund, L., and R. Ramakrishnan. 2004. Lipoprotein (a): an elusive cardiovascular risk factor. Arterioscler. Thromb. Vasc. Biol. 24: 2219-2226. (Pubitemid 39658021)
2. Utermann, G., H. J. Menzel, H. G. Kraft, H. C. Duba, H. G. Kemmler, and C. Seitz. 1987. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80: 458-465.
3. Gaubatz, J. W., K. I. Ghanem, J. Guevara, Jr., M. L. Nava, W. Patsch, and J. D. Morrisett. 1990. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weight to plasma levels of lipoprotein(a). J. Lipid Res. 31: 603-613.
4. Suk Danik, J., N. Rifai, J. E. Buring, and P. M. Ridker. 2006. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA. 296: 1363-1370.
5. Ariyo, A. A., C. Thach, and R. Tracy. 2003. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N. Engl. J. Med. 349: 2108-2115. (Pubitemid 37464535)
6. Jones, G. T., A. M. van Rij, J. Cole, M. J. A. Williams, E. H. Bateman, S. M. Marcovina, M. Deng, and S. P. A. McCormick. 2007. Plasma lipoprotein(a) indicates risk for 4 distinct form of vascular disease. Clin. Chem. 53: 679-685.
7. Wild, S. H., S. P. Fortmann, and S. M. Marcovina. 1997. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler. Thromb. Vasc. Biol. 17: 239-245.
8. Longenecker, J. C., M. J. Klag, S. M. Marcovina, N. R. Powe, N. E. Fink, F. Giaculli, and J. Coresh. 2002. Small apolipoprotein(a) size predicts mortality in end stage renal disease: the CHOICE study. Circulation. 106: 2812-2818.
9. Dieplinger, B., A. Lingenhel, N. Baumgartner, W. Poelz, H. Displinger, M. Haltmayer, F. Kronenberg, and T. Mueller. 2007. Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin. Chem. 53: 1298-1305. (Pubitemid 47020986)
10. Longenecker, J. C., M. J. Klag, S. M. Marcovina, Y-M. Lui, B. G. Jaar, N. R. Powe, N. E. Fink, A. S. Levey, and J. Coresh. 2005. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. J. Am. Soc. Nephrol. 16: 1794-1802.
11. Jurgens, G., W. C. Taddei-Peters, P. Koltringer, W. Petek, Q. Chen, J. Greilberger, P. F. Macomber, B. T. Butman, A. G. Stead, and J. H. Ransom. 1995. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke. 26: 1841-1848.
12. Nauck, M., K. Winker, W. Marz, and H. Wieland. 1995. Quantitative determination of high-, low-, and very-low-density lipoprotein and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining. Clin. Chem. 41: 1761-1767.
13. Sato, I., T. Taniguchi, Y. Ishikawa, M. Kusuki, F. Hayashi, M. Mukai, S. Kawano, S. Kondo, S. Yamashita, and S. Kumagai. 2006. The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis refl ects serum remnant lipoprotein and Lp(a) concentrations. J. Atheroscler. Thromb. 13: 55-61.
14. Usui, S., H. Kakuuchi, M. Okamoto, Y. Mizukami, and M. Okazaki. 2002. Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. Clin. Chem. 48: 1946-1954. (Pubitemid 35222753)
15. Gaubatz, J. W., M. V. Chari, M. L. Nava, J. R. Guyton, and J. D. Morrisett. 1987. Isolation and characterization of the two major apoproteins in human lipoprotein(a). J. Lipid Res. 28: 69-79.
16. Kostner, G. M., A. Ibovnik, H. Holzer, and H. Grillhofer. 1999. Preparation of stable fresh frozen primary lipoprotein(a) (Lp(a)) standard. J. Lipid Res. 40: 2255-2263.
17. Hirowatari, Y., H. Yoshida, H. Kurosawa, K. Doumitu, and N. Tada. 2003. Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J. Lipid Res. 44: 1404-1412. (Pubitemid 37279623)
18. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
19. Schumaker, V. N., and D. L. Puppione. 1986. Sequential fl otation ultracentrifugation. Methods Enzymol. 128: 155-170.
20. Berneis, K. K., and R. M. Krauss. 2002. Metabolic origns and clinical signifi cance of LDL heterogeneity. J. Lipid Res. 43: 1363-1379.
21. Ensign, W., N. Hill, and C. B. Heward. 2006. Disparate LDL phenotypic classifi cation among 4 different methods assessing LDL particle characteristics. Clin. Chem. 52: 1722-1727. (Pubitemid 44330706)
22. Wood, R. J., J. S. Volek, Y. Liu, N. S. Shachter, J. H. Contois, and M. L. Fernabdez. 2006. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. J. Nutr. 136: 384-389.
23. Nestel, P., T. Billington, N. Tada, P. Nugent, and N. Fidge. 1983. Heterogenety of very-low-density lipoprotein metabolism in hyperlipidemic subjects. Metabolism. 32: 810-817. (Pubitemid 13026349)
24. Winocour, P. H., P. N. Durrington, D. Bhatnager, M. Ishola, M. Mackness, and S. Arrol. 1991. Infl uence of early diabetic nephropathy of very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition. Atherosclerosis. 89: 49-57.
25. Dachet, C., E. Cavallero, C. Martin, G. Girardot, and B. Jacotot. 1995. Effect of gemfi brozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients. Atherosclerosis. 113: 1-9.
26. Meyer, B. J., M. J. Caslake, M. M. McConnell, and C. J. Packard. 2000. Two subpopulations of intermediate density lipoprotein and their relationship to plasma triglyceride and cholesterol levels. Atherosclerosis. 153: 355-362.
27. Gotto, A. M., Jr., H. J. Pownall, and R. J. Havel. 1986. Introduction to the plasma lipoproteins. Methods Enzymol. 128: 3-41.